Cinctive Capital Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-110,000
Closed -$2.05M 687
2022
Q1
$2.05M Buy
+110,000
New +$1.98M 0.08% 325
2021
Q4
Sell
-66,930
Closed -$1.24M 694
2021
Q3
$1.24M Sell
66,930
-114,652
-63% -$2.31M 0.06% 368
2021
Q2
$3.89M Sell
181,582
-134,308
-43% -$2.73M 0.18% 176
2021
Q1
$6.09M Buy
+315,890
New +$5.57M 0.37% 83

Other funds holding OCDX

Cinctive Capital Management's OCDX Position: Q2 2022 in Review

Cinctive Capital Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 110,000 shares — an estimated $2.05M sold.

Cinctive Capital Management first reported a position in OCDX in Q1 2021 and held it in 4 quarters. The position peaked at $6.09M in Q1 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Cinctive Capital Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Cinctive Capital Management sold 110,000 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $2.05M.
  • Cinctive Capital Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 4 quarters.
  • Cinctive Capital Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $6.09M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Cinctive Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.